- Home
- IMTE vs CYTO Comparison
IMTE vs CYTO Comparison
Compare IMTE & CYTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- CYTO
- Stock Information
- Founded
- IMTE 2008
- CYTO 2003
- Country
- IMTE Malaysia
- CYTO Bermuda
- Employees
- IMTE N/A
- CYTO N/A
- Industry
- IMTE Consumer Electronics/Appliances
- CYTO Biotechnology: Pharmaceutical Preparations
- Sector
- IMTE Consumer Staples
- CYTO Health Care
- Exchange
- IMTE Nasdaq
- CYTO Nasdaq
- Market Cap
- IMTE 2.6M
- CYTO 2.4M
- IPO Year
- IMTE N/A
- CYTO N/A
- Fundamental
- Price
- IMTE $1.18
- CYTO $0.62
- Analyst Decision
- IMTE
- CYTO
- Analyst Count
- IMTE 0
- CYTO 0
- Target Price
- IMTE N/A
- CYTO N/A
- AVG Volume (30 Days)
- IMTE 3.9K
- CYTO 55.7K
- Earning Date
- IMTE 10-22-2024
- CYTO 09-24-2024
- Dividend Yield
- IMTE N/A
- CYTO N/A
- EPS Growth
- IMTE N/A
- CYTO N/A
- EPS
- IMTE N/A
- CYTO N/A
- Revenue
- IMTE N/A
- CYTO N/A
- Revenue This Year
- IMTE N/A
- CYTO N/A
- Revenue Next Year
- IMTE N/A
- CYTO N/A
- P/E Ratio
- IMTE N/A
- CYTO N/A
- Revenue Growth
- IMTE 174.26
- CYTO N/A
- 52 Week Low
- IMTE $1.02
- CYTO $0.58
- 52 Week High
- IMTE $4.57
- CYTO $17.20
- Technical
- Relative Strength Index (RSI)
- IMTE 43.58
- CYTO 39.08
- Support Level
- IMTE $1.17
- CYTO $0.58
- Resistance Level
- IMTE $1.38
- CYTO $0.75
- Average True Range (ATR)
- IMTE 0.09
- CYTO 0.04
- MACD
- IMTE 0.00
- CYTO 0.01
- Stochastic Oscillator
- IMTE 37.50
- CYTO 32.50
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the development, sale and distribution of autostereoscopic 3D displays, conversion equipment, software and technology solutions, and others, Sales of air-filter products, provision of consultancy services, and Sales of Halal products.
About CYTO Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.